Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13706184 | 0.72 | LMNA (0.33) | TSHRLMNA | |
| SCHEMBL28879164 | 0.72 | LMNA (0.33) | TSHRLMNA | |
| SCHEMBL27763408 | 0.71 | HSD17B10 (0.34) | TSHRLMNA | |
| SCHEMBL6650162 | 0.70 | LMNA (0.33) | TSHRLMNA | |
| SCHEMBL5609089 | 0.69 | HSD17B10 (0.33) | TSHRLMNA | |
| SCHEMBL27474770 | 0.69 | HSD17B10 (0.33) | TSHRLMNA | |
| SCHEMBL3687003 | 0.67 | ATP1A1 (0.34) | TSHRLMNA | |
| SCHEMBL5357561 | 0.67 | ATP1A1 (0.34) | TSHRLMNA | |
| Cadaverine Tartrate SCHEMBL28304662 | 0.66 | TSHR (0.53) | TSHRNFKB1CYP2C19LMNA | |
| SCHEMBL28784245 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1132369-B1 | Malic acid and oxalacetic acid derivatives | DAICEL CHEM (JP) | 2004-06-09 | — | — | EP | disclosed |
| US-6489504-B2 | Malic acid and oxalacetic acid derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-12-03 | — | — | US | disclosed |
| US-20010056120-A1 | Malic acid and oxalacetic acid derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2001-12-27 | — | — | US | disclosed |
| EP-1132369-A1 | Malic acid and oxalacetic acid derivatives | Daicel Chemical Industries, Ltd. (JP) | 2001-09-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010056120-A1 | Malic acid and oxalacetic acid derivatives | ME1, ME3, MLYCD | TSHR 3998/4885NFKB1 1748/4885CYP2C19 1100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.